Xiangfan Liu
- Molecular Biology top 5%
- Cancer Research top 2%
- Cell Biology top 5%
- Oncology
- Epidemiology
- Topics
- Hippo pathway signaling and YAP/TAZ (8 papers)Ubiquitin and proteasome pathways (5 papers)MicroRNA in disease regulation (4 papers)
- Partner nations
- ChinaUnited States
In The Last Decade
Xiangfan Liu
23 papers receiving 1.7k citations
Hit Papers
Peers
Comparison fields: 5 of 78
- Molecular Biology 1.4k
- Cancer Research 1.0k
- Cell Biology 372
- Oncology 134
- Epidemiology 129
Countries citing papers authored by Xiangfan Liu
This map shows the geographic impact of Xiangfan Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiangfan Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiangfan Liu more than expected).
Fields of papers citing papers by Xiangfan Liu
This network shows the impact of papers produced by Xiangfan Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiangfan Liu. The network helps show where Xiangfan Liu may publish in the future.
Co-authorship network of co-authors of Xiangfan Liu
This figure shows the co-authorship network connecting the top 25 collaborators of Xiangfan Liu. A scholar is included among the top collaborators of Xiangfan Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiangfan Liu. Xiangfan Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 13 | |
| 2 | 35 | |
| 3 | 33 | |
| 4 | 44 | |
| 5 | 205 | |
| 6 | 64 | |
| 7 | 1 | |
| 8 | 176 | |
| 9 | 54 | |
| 10 | Association of three common BARD1 variants with cancer susceptibility: a system review and meta-analysis. | 1 |
| 11 | 14 | |
| 12 | 102 | |
| 13 | 19 | |
| 14 | 8 | |
| 15 | 21 | |
| 16 | 51 | |
| 17 | 19 | |
| 18 | CREB up-regulates long non-coding RNA, HULC expression through interaction with microRNA-372 in liver cancerbreakdown → | 841 |
| 19 | Polymorphisms of the coagulation factor VII gene and its plasma levels in relation to acute cerebral infarction differences in allelic frequencies between Chinese Han and European populations. | 11 |
| 20 | [Gene diagnosis of hemophilia B by multiple STR analysis]. | 2 |
About Xiangfan Liu
Xiangfan Liu is a scholar working on Cell Biology, Cancer Research and Immunology and Allergy, having authored 23 papers that have together received 1.7k indexed citations. Recurring topics across this work include Hippo pathway signaling and YAP/TAZ (8 papers), Ubiquitin and proteasome pathways (5 papers) and MicroRNA in disease regulation (4 papers). The work is most often cited by research in Cancer Research (1.0k citations), Cell Biology (372 citations) and Molecular Biology (1.4k citations). Xiangfan Liu has collaborated with scholars based in China and United States. Frequent co-authors include Jiayi Wang, Yongxia Qiao, Peihua Ni, Qishi Fan, Zhidong Gu, Ning Chen, Fenyong Sun, Huacheng Wu, Fenyong Sun and Qiuhui Pan. Their work appears in journals such as Nucleic Acids Research, Nature Communications and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.